Clinical Research Directory
Browse clinical research sites, groups, and studies.
Efficacy and Safety of Trabecular Meshwork Microstent Drainage System ( MicroCOGO )
Sponsor: Healthguard Biomed
Summary
It is a prospective, multicenter, randomized, open label, parallel controlled, superiority clinical trial that evaluate efficacy and safety of Trabecular Meshwork Microstent Drainage System in Reducing Intraocular Pressure in Adult Patients With Mild to Moderate Open-angle Glaucoma Combined With Cataract.
Official title: Efficacy and Safety of Trabecular Meshwork Microstent Drainage System in Reducing Intraocular Pressure in Adult Patients with Mild to Moderate Open-angle Glaucoma Combined with Cataract: a Prospective, Multicenter, Randomized, Open Label, Parallel Controlled, Superiority Clinical Trial
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
207
Start Date
2022-10-19
Completion Date
2026-05-04
Last Updated
2024-12-19
Healthy Volunteers
No
Conditions
Interventions
Trabecular Meshwork Microstent Drainage System
The device is implanted on the functional trabecular meshwork with head in schlemm canal and tail in anterior chamber. There is a hollow tube connecting schlemm canal and anterior chamber. The device can promote external drainage of aqueous humor to reduce intraocular pressure.
phacoemulsification
Eyes with OAG and cataracts randomly divided into control group that were planned for phacoemulsification alone.
Locations (1)
Healthguard Biomed
Suzhou, Jiangsu, China